Accounting for EGFR Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

Author:

Schmid Sabine12,Jiang Mei3ORCID,Brown M. Catherine1ORCID,Fares Aline4,Garcia Miguel1,Soriano Joelle15,Dong Mei16ORCID,Thomas Sera7,Kohno Takashi8ORCID,Leal Leticia Ferro9,Diao Nancy10ORCID,Xie Juntao11,Wang Zhichao1213ORCID,Zaridze David14,Holcatova Ivana15,Lissowska Jolanta16,Świątkowska Beata17ORCID,Mates Dana18ORCID,Savic Milan19,Wenzlaff Angela S.20ORCID,Harris Curtis C.21,Caporaso Neil E.22,Ma Hongxia23,Fernandez-Tardon Guillermo24ORCID,Barnett Matthew J.25ORCID,Goodman Gary26,Davies Michael P.A.27ORCID,Pérez-Ríos Mónica2829,Taylor Fiona3031,Duell Eric J.3233ORCID,Schoettker Ben3435,Brenner Hermann34353637ORCID,Andrew Angeline38,Cox Angela30ORCID,Ruano-Ravina Alberto2829ORCID,Field John K.27ORCID,Marchand Loic Le39,Wang Ying40,Chen Chu41,Tardon Adonina24ORCID,Shete Sanjay42,Schabath Matthew B.43ORCID,Shen Hongbing23,Landi Maria Teresa22,Ryan Brid M.21,Schwartz Ann G.20ORCID,Qi Lihong44,Sakoda Lori C.45ORCID,Brennan Paul46ORCID,Yang Ping12ORCID,Zhang Jie11,Christiani David C.10ORCID,Reis Rui Manuel94748ORCID,Shiraishi Kouya8,Hung Rayjean J.67ORCID,Xu Wei16,Liu Geoffrey16ORCID

Affiliation:

1. 1The Princess Margaret Cancer Centre and University Health Network, University of Toronto, Toronto, Ontario, Canada.

2. 2Department of Medical Oncology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.

3. 3State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.

4. 4Division of Medical Oncology, Hospital de Base de São José do Rio Preto, SP, Brazil.

5. 5University of Ottawa, Ottawa, Ontario, Canada.

6. 6Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

7. 7Lunenfeld-Tanenbaum Research Institute, Sinai Health Systems, Toronto, Ontario, Canada.

8. 8Division of Genome Biology, National Cancer Centre Research Institute, Tokyo, Japan.

9. 9Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.

10. 10Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

11. 11Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

12. 12Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.

13. 13Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.

14. 14Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.

15. 15Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.

16. 16Department of Cancer Epidemiology and Prevention, M. Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.

17. 17The Nofer Institute of Occupational Medicine, Lodz, Poland.

18. 18National Institute of Public Health, Bucharest, Romania.

19. 19Department of Thoracic Surgery, Clinical Center of Serbia, Belgrade, Serbia.

20. 20Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan.

21. 21Laboratory of Human Carcinogenesis, Centre for Cancer Research, National Institutes of Health, Bethesda, Maryland.

22. 22Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

23. 23Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, China.

24. 24IUOPA, University of Oviedo, and ISPA (Health Research Institute of the Principality of Asturias) and CIBERESP, Asturias, Spain.

25. 25Program in Biostatistics Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.

26. 26Swedish Cancer Institute, Seattle, Washington.

27. 27Roy Castle Lung Cancer Research Programme, The University of Liverpool, Department of Molecular and Clinical Cancer Medicine, Liverpool, United Kingdom.

28. 28Department of Preventive Medicine and Public Health, University of Santiago de Compostela, Galicia, Spain.

29. 29CIBER de Epidemiología y Salud Pública, CIBERESP, Santiago de Compostela, Galicia, Spain.

30. 30Department of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, United Kingdom.

31. 31Sheffield Teaching Hospitals Foundation Trust, Sheffield, United Kingdom.

32. 32Catalan Institute of Oncology (ICO), Barcelona, Spain.

33. 33Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

34. 34Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

35. 35Network of Aging Research, Heidelberg University, Heidelberg, Germany.

36. 36Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.

37. 37German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

38. 38Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.

39. 39University of Hawaii Cancer Center, Honolulu, Hawaii.

40. 40American Cancer Society, Atlanta, Georgia.

41. 41Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.

42. 42The University of Texas MD Anderson Cancer Center, Houston, Texas.

43. 43Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida.

44. 44The University of California Davis Medical Sciences, Davis, California.

45. 45Kaiser Permanente Northern California, Division of Research, Oakland, California.

46. 46International Agency for Research on Cancer, Lyon, France.

47. 47Life and Health Sciences Research Institute (ICVS), Medical School, University of Minho, Braga, Portugal.

48. 48ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.

Abstract

Abstract Background: Somatic EGFR mutations define a subset of non–small cell lung cancers (NSCLC) that have clinical impact on NSCLC risk and outcome. However, EGFR-mutation-status is often missing in epidemiologic datasets. We developed and tested pragmatic approaches to account for EGFR-mutation-status based on variables commonly included in epidemiologic datasets and evaluated the clinical utility of these approaches. Methods: Through analysis of the International Lung Cancer Consortium (ILCCO) epidemiologic datasets, we developed a regression model for EGFR-status; we then applied a clinical-restriction approach using the optimal cut-point, and a second epidemiologic, multiple imputation approach to ILCCO survival analyses that did and did not account for EGFR-status. Results: Of 35,356 ILCCO patients with NSCLC, EGFR-mutation-status was available in 4,231 patients. A model regressing known EGFR-mutation-status on clinical and demographic variables achieved a concordance index of 0.75 (95% CI, 0.74–0.77) in the training and 0.77 (95% CI, 0.74–0.79) in the testing dataset. At an optimal cut-point of probability-score = 0.335, sensitivity = 69% and specificity = 72.5% for determining EGFR-wildtype status. In both restriction-based and imputation-based regression analyses of the individual roles of BMI on overall survival of patients with NSCLC, similar results were observed between overall and EGFR-mutation-negative cohort analyses of patients of all ancestries. However, our approach identified some differences: EGFR-mutated Asian patients did not incur a survival benefit from being obese, as observed in EGFR-wildtype Asian patients. Conclusions: We introduce a pragmatic method to evaluate the potential impact of EGFR-status on epidemiological analyses of NSCLC. Impact: The proposed method is generalizable in the common occurrence in which EGFR-status data are missing.

Funder

NIH NCI

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3